Medelis is accustomed to working closely with other cutting-edge organizations in their respective fields in a “best-in-class” partnership model. With this model, no single organization is deviating from its core competencies by trying to be all things to all people.
Each organization takes pride in its unique service offerings and is able to provide the most talented resources and highest quality service in their respective core competencies. This combination of specialized services gives sponsors a level of responsiveness and attention rarely delivered by large CROs.
Our partners include:
National Foundation for Cancer Research
Founded in 1973, the National Foundation for Cancer Research (NFCR) supports the work of proven scientists with the funding to accelerate research into the prevention, diagnosis and treatment of cancer. Cumulatively, the organization has provided more than $200 million to support discovery-oriented research, and remains determined to assist in the exploration of previously uncharted territories for potential anticancer agents. NFCR and Medelis have joined forces to take advantage of NFCR’s strong international ties to open U.S.-style clinical research organizations in India, China and elsewhere in Asia. These new organizations will offer pharmaceutical and biotechnology companies access to clinical research services with lower cost structures and dramatically improved access to largely untapped patient populations.
Insight Genetics
Insight Genetics is a molecular diagnostics company that is working to further precision cancer care at times of diagnosis, treatment and therapeutic resistance through the discovery, development and commercialization of companion diagnostics.
Many cancer therapies are being developed to target specific genetic biomarkers. Insight Genetics develops fast, accurate and comprehensive tests to help clinicians pinpoint which targeted therapies may or may not work for a particular patient.
In addition, Insight Genetics’ CLIA-certified Insight Molecular Labs provides unique, high-value cancer testing services to oncologists and pharmaceutical companies.
The McGuire Institute
Founded by Dr. Michael K. McGuire and Dr. E. Todd Scheyer, The McGuire Institute is a non-profit organization focused on delivering highly relevant clinical research that supports clients’ goals and advances the profession through the adoption of new or improved technologies in practice.
Medelis, in partnership with The McGuire Institute, allows study sponsors to initiate single or multi-centered studies quickly and reliably, with calibration and internal communications coordinated by the Institute and study management handled by the clinical research professionals at Medelis.
Brightech
Brightech is recognized as an innovator shaped by our industry-leading approach, clinical data methodology and client centric focus. We provide comprehensive end-to-end data services in clinical data management, biostatistics / SAS programming, clinical data standardization, regulatory submissions, and medical writing resulting in successful clinical trial activities.
Eurofins
Eurofins Scientific through its subsidiaries believes it is the world leader in food, environment and pharmaceutical products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supporting clinical studies.
Adhoc
Ad Hoc Clinical assists in the set-up and management of clinical research through functional sourcing and study conduct services.
Clinical research is an essential step to verify the safety and efficacy of newly discovered drugs/medical devices/in vitro diagnostics.
This type of research is generally conducted in an international setting and subject to important ethical considerations and very stringent international and local rules and regulations.
Ad Hoc Clinical provides consultancy and/or hands-on assistance with different aspects of clinical research in Europe.
Relationships are important to us. Reach out to learn more about how our approach, experience, investigator relationships, bid transparency and flexibility deliver success for our clients.